Does SECUKINUMAB Cause Renal cell carcinoma? 26 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Renal cell carcinoma have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.0% of all adverse event reports for SECUKINUMAB.
26
Reports of Renal cell carcinoma with SECUKINUMAB
0.0%
of all SECUKINUMAB reports
0
Deaths
10
Hospitalizations
How Dangerous Is Renal cell carcinoma From SECUKINUMAB?
Of the 26 reports, 10 (38.5%) required hospitalization, and 5 (19.2%) were considered life-threatening.
Is Renal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Renal cell carcinoma?
CABOZANTINIB S-MALATE (451)
SUNITINIB MALATE (361)
PAZOPANIB (244)
AXITINIB (154)
RANITIDINE (143)
EVEROLIMUS (130)
SORAFENIB (118)
METHOTREXATE (116)
ADALIMUMAB (105)
PREDNISONE (101)
Which SECUKINUMAB Alternatives Have Lower Renal cell carcinoma Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG